S&P, Nasdaq Close Higher on vaccine Hopes & Improving Economic Data
Pfizer Inc’s shares rose more than 3% after the drug-maker said a COVID-19 vaccine being developed with German biotech firm BioNTech showed promise and was found to be well-tolerated in early-stage human trials.
Read moreDetails